Hays Advisory’s United Therapeutics UTHR Stock Holding History

Hays Advisory’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,492	Closed	-$1.21M	–	58
2018 Q3	$1.21M	Sell	9,492 -230	-2%	-$28.4K	0.77%	36
2018 Q2	$1.1M	Sell	9,722 -705	-7%	-$77.5K	0.61%	38
2018 Q1	$1.17M	Sell	10,427 -4,402	-30%	-$559K	0.57%	41
2017 Q4	$2.19M	Sell	14,829 -6,975	-32%	-$887K	0.78%	36
2017 Q3	$2.56M	Sell	21,804 -2,003	-8%	-$256K	0.74%	37
2017 Q2	$3.09M	Sell	23,807 -2,963	-11%	-$370K	0.75%	36
2017 Q1	$3.62M	Sell	26,770 -2,007	-7%	-$304K	0.85%	35
2016 Q4	$4.13M	Sell	28,777 -9,433	-25%	-$1.2M	0.92%	30
2016 Q3	$4.51M	Sell	38,210 -3,993	-9%	-$480K	0.75%	33
2016 Q2	$4.47M	Sell	42,203 -6,897	-14%	-$769K	0.69%	34
2016 Q1	$5.47M	Buy	+49,100	New	+$6.21M	0.77%	37
2015 Q1	–	Sell	-118,047	Closed	-$15.3M	–	80
2014 Q4	$15.3M	Sell	118,047 -10,441	-8%	-$1.35M	2.05%	15
2014 Q3	$16.5M	Sell	128,488 -5,650	-4%	-$582K	2.19%	15
2014 Q2	$11.9M	Sell	134,138 -8,202	-6%	-$789K	1.49%	32
2014 Q1	$13.4M	Sell	142,340 -38,659	-21%	-$3.95M	1.63%	29
2013 Q4	$20.5M	Sell	180,999 -2,921	-2%	-$263K	2.48%	12
2013 Q3	$14.5M	Sell	183,920 -2,445	-1%	-$179K	1.87%	27
2013 Q2	$12.3M	Buy	+186,365	New	+$12M	1.74%	31

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hays Advisory's UTHR Position: Q4 2018 in Review

Hays Advisory sold out of United Therapeutics (UTHR) in Q4 2018, closing a stake of 9,492 shares — an estimated $1.21M sold.

Hays Advisory first reported a position in UTHR in Q2 2013 and held it in 18 quarters. The position peaked at $20.5M in Q4 2013. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

Hays Advisory reported no remaining United Therapeutics position as of Q4 2018 after selling out during the quarter.
Hays Advisory sold 9,492 United Therapeutics shares in Q4 2018, an estimated $1.21M.
Hays Advisory first reported a position in United Therapeutics in Q2 2013 and held it in 18 quarters.
Hays Advisory's United Therapeutics position peaked at $20.5M in Q4 2013.
360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.